Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3031-3033

  Oremek, G M ^a   Eigenbrodt, E ^b   Radle J ^a   Zeuzem, S T ^a   Seiffert, U B ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Pancreatic cancer; TUM2 PK; Tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CA 50 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUM2 PK; TUMOR MARKER; UNCLASSIFIED DRUG;

BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PANCREAS CANCER; PRIORITY JOURNAL; REGRESSION ANALYSIS; STOMACH CANCER;

HUMANS; ISOENZYMES; PANCREATIC NEOPLASMS; PYRUVATE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030822256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R: Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Critical Rev Oncogenesis 3: 91-115, 1992.
2. Scheefers-Borchel U, Scheefers H, Michel A, Will H, Fischer G, Basenau D, Dahlmann N, Laumen R, Mazurek S, Eigenbrodt E: Quantitative determination (ELISA) of pyruvatkinase type tumor M2. in Current Diagnosis, Klapdor R (ed), W. Zuckschwerdt Verlag, München, 1994.
3. Oremek GM, Seiffert UB, Wagner R: Tu-M2-PK: Ein neuer Tumormarker in der pneumologischen Diagnostik. Atemw.-Lungenkrkh 21: 340-342, 1995.
4. Bruhn HD, Broers H, Euler H, Everding A, Feller A.C, Hedderich J, Jostarndt L, Jooß B, Zurborn KH, Löffler H: CA-50 im Serum von Karzinom-Patienten. Dtsch med Wschr 111: 1267-1272, 1986.
5. Habib N.A, Hershman M.J, Haberland F, Papp L, Wood C.B, Williamson R.C.N: The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. Br J Cancer 53: 697-699, 1986.
6. Hamazoe R, Maeta M, Matsui T, Shibuta S, Shiota S, Kaibra N: CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer. Eur J Cancer 28: 1351-1354, 1992.
7. Lüthgens K: Indikationsgebiete für Tumormarker. Clin. Lab 41: 567-572, 1995.